
SPR Therapeutics Raises $5 Million Series A
Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors.
Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors.